Bayer says Phase III Xarelto study halted early

  1. Bayer says Phase III Xarelto study halted early  Reuters
  2. NAVIGATE ESUS Study Stopped Early Due to Comparable Efficacy in Treatment Arms  PR Newswire
  3. Bayer sticks by Xarelto sales estimate despite study setback  Daily MailFull coverage

posted from Health - Google News
Thank you for reading the Bayer says Phase III Xarelto study halted early on Syria News Kit If you want to spread this News please include links as Source, and if this News useful please bookmark this page in your web browser, by pressing Ctrl + D on your keyboard button, Or click the share button to place it on your profile.

Latest news:

Note: Only a member of this blog may post a comment.